Gilgamesh’s pipeline is driven by its proprietary drug discovery platform, which combines “advanced behavioral assessments, Sophisticated electrophysiology and molecular measures of neuroplasticity” to recognize and layout novel medicines, in accordance with the biotech’s website."Very first cannabis, now hallucinogens and… Read More